The proinflammatory cytokine interleukin-1 binds to two cell-surface r
eceptors. The type I receptor, an 80-kDa protein with a cytoplasmic do
main of approximate to 215 amino acids, mediates the biological effect
s of IL-1. The type II receptor, a 60-kDa protein with 29 cytoplasmic
amino acids, binds IL-1 and thereby prevents it from binding to the ty
pe I receptor but does not deliver a biological signal. Thus, the type
II receptor acts as a negative regulator of IL-1 actions. It can do s
o either as a membrane-bound molecule or subsequent to shedding from t
he cell surface to generate a so-called ''soluble'' receptor. Both the
naturally produced soluble type II receptor and the recombinantly gen
erated soluble type I receptor are effective inhibitors of IL-1 action
. The soluble type I receptor has shown efficacy in some preclinical m
odels of inflammatory diseases, as well as in an initial clinical tria
l in a setting of cutaneous allergy. (C) 1994 Academic Press, Inc.